Damien Tan

668 total citations
16 papers, 462 citations indexed

About

Damien Tan is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Damien Tan has authored 16 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Damien Tan's work include CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers) and CRISPR and Genetic Engineering (3 papers). Damien Tan is often cited by papers focused on CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers) and CRISPR and Genetic Engineering (3 papers). Damien Tan collaborates with scholars based in Singapore, United Kingdom and United States. Damien Tan's co-authors include Antonio Bertoletti, Navjyot Hansi, Patrick Kennedy, Yang Cheng, Laura Rivino, Nina Le Bert, Upkar S. Gill, Evan W. Newell, Kamini Kunasegaran and Andrea Pavesi and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Damien Tan

15 papers receiving 455 citations

Peers

Damien Tan

EPIDE

HEPAT

IMMUN

ONCOL

Hong Seok Kang South Korea

Gavin Whitehouse United Kingdom

Eleonora Cremonesi Switzerland

S. Khan Canada

Cristian G. Beccaría Argentina

Brynn B. Duncan United States

Immacolata Zampaglione Italy

Keisuke Kosai United States

Thomas N. Burn United States

Mohammed-Alkhatim Ali United States

Hong Seok Kang South Korea

Damien Tan

143 ×0.5

EPIDE

69 ×0.3

HEPAT

42 ×0.3

IMMUN

27 ×0.3

ONCOL

91 ×1.1

Citations per year, relative to Damien Tan Damien Tan (= 1×) peers Hong Seok Kang

Countries citing papers authored by Damien Tan

Since Specialization

Citations

This map shows the geographic impact of Damien Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Tan more than expected).

Fields of papers citing papers by Damien Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Tan. The network helps show where Damien Tan may publish in the future.

Co-authorship network of co-authors of Damien Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Tan. A scholar is included among the top collaborators of Damien Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Tan. Damien Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Reales‐Calderón, Jose Antonio, Maxine Lam, Jin Rong Ow, et al.. (2025). In vitro integration of a functional vasculature to model endothelial regulation of chemotherapy and T-cell immunotherapy in liver cancer. Biomaterials. 320. 123175–123175. 3 indexed citations

Tan, Damien, Hui Yi Grace Lim, Swathi Yada, et al.. (2023). Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma (Small 52/2023). Small. 19(52). 1 indexed citations

Lam, Maxine, Jose Antonio Reales‐Calderón, Jin Rong Ow, et al.. (2023). G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature Communications. 14(1). 563–563. 14 indexed citations

Lin, Meiyin, S Bhakdi, Damien Tan, et al.. (2023). Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood. PubMed. 3(1). ltad015–ltad015. 2 indexed citations

Tan, Damien, et al.. (2023). Abstract 2501: A glioblastoma and blood-brain barrier in vitro model to assess the tumor microenvironment and temozolomide resistance. Cancer Research. 83(7_Supplement). 2501–2501.

Lam, Maxine, Damien Tan, Hui Yi Grace Lim, et al.. (2023). Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma. Small. 19(52). e2302280–e2302280. 19 indexed citations

Reales‐Calderón, Jose Antonio, et al.. (2023). Abstract 4612: Microphysiological vascularized solid liver tumor model for drug and cell therapy. Cancer Research. 83(7_Supplement). 4612–4612. 1 indexed citations

Tan, Alrina, et al.. (2021). A 3D pancreatic tumor model to study T cell infiltration. Biomaterials Science. 9(22). 7420–7431. 24 indexed citations

Bert, Nina Le, Upkar S. Gill, Michelle Hong, et al.. (2020). Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection. Gastroenterology. 159(2). 652–664. 108 indexed citations

10.

Preece, Roland, Andrea Pavesi, Soragia Athina Gkazi, et al.. (2020). CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity. Molecular Therapy — Methods & Clinical Development. 19. 149–161. 20 indexed citations

11.

Hafezi, Morteza, Meiyin Lin, Adeline Chia, et al.. (2020). Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients. Hepatology. 74(1). 200–213. 38 indexed citations

12.

Otano, Itziar, David Escors, Anna Schurich, et al.. (2018). Molecular Recalibration of PD-1+ Antigen-Specific T Cells from Blood and Liver. Molecular Therapy. 26(11). 2553–2566. 21 indexed citations

13.

Tabaglio, Tommaso, Diana Low, Pierre-Alexis Goy, et al.. (2018). MBNL1 alternative splicing isoforms play opposing roles in cancer. Life Science Alliance. 1(5). e201800157–e201800157. 42 indexed citations

14.

Rivino, Laura, Nina Le Bert, Upkar S. Gill, et al.. (2018). Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation. Journal of Clinical Investigation. 128(2). 668–681. 154 indexed citations

15.

Zhao, Jian, Ling Pei, Jian Wang, et al.. (2012). Evaluation of entropy for monitoring the depth of anesthesia compared with bispectral index: a multicenter clinical trial.. PubMed. 125(8). 1389–92. 14 indexed citations

16.

Bhadkamkar, Nishin A., M. M. Javle, Robert A. Wolff, William D. Payne, & Damien Tan. (2010). Osteoclastic giant cell tumor of the pancreas: A distinct clinical and pathologic entity.. Journal of Clinical Oncology. 28(15_suppl). e14648–e14648. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact